See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Trade War
Artificial Intelligence
Donald Trump
Trade
Social Media
Stock Markets
Natural Disasters
Baseball
European Union
Education
Taxes
Published • loading... • Updated

Compass Therapeutics (NASDAQ:CMPX) Receives Outperform Rating from Wedbush

Summary by marketbeat.com
Wedbush restated an "outperform" rating and set a $8.00 price objective on shares of Compass Therapeutics in a research note on Tuesday.

1 Articles

All
Left
Center
1
Right
marketbeat.commarketbeat.com
Center

Compass Therapeutics (NASDAQ:CMPX) Receives Outperform Rating from Wedbush

Wedbush restated an "outperform" rating and set a $8.00 price objective on shares of Compass Therapeutics in a research note on Tuesday.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal